Navigation Links
GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
Date:9/8/2009

s Ph.D thesis in Molecular Biology and Genetics in 1994.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genova files patent for new prostate cancer treatment
2. GENova names Dr. John Savin as Vice President
3. GENova names Aaron Whiteman as CEO
4. Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations
5. KV Pharmaceutical Appoints Interim Chief Financial Officer
6. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
7. Mindray DS USA Appoints Michael Thompson Vice President of U.S. Ultrasound Sales
8. XLHealth Appoints New Controller to Lead Financial Compliance, Accounting Initiatives
9. IMIA Interpreter Association Appoints Brazil Representative
10. HCA Appoints Dr. Richard Tayrien Chief Health Information Officer
11. SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...The Center for Science Writings at Stevens Institu...d," a talk by Robert Wright, journalist and founde...4:00-5:30 p.m. at the Babbio Center for Technology...to the public and the media., In his new book "T...obert Wright, renowned for his popular works on ev...
(Date:11/23/2009)...09 -- Exposure shortly after birth to ambient meta...ticles from diesel emissions are associated with r...according to a new study by researchers at the Col...CCCEH) at Columbia University,s Mailman School of ...the effects of exposure to airborne metals in this...
(Date:11/23/2009)...ome-based settings get far more screen time than ... , MONDAY, Nov. 23 (HealthDay News) --Young child...ion every day than previous reports have found, es...ew study finds. , Researchers from Seattle Chil...urveyed day-care directors to find out how much te...
(Date:11/23/2009)...LIS,Nov.23/PRNewswire/--ThousandsofpeoplewithiPhon...edtohelppeoplewithdiabetesbettermanagetheirdisease...ndwhattheycandotobettermanagetheirbloodsugar.Nowit...uddyavailablenow. ,, RocheDiabetesCare,themaker...ulindeliverysystems,haspartneredwithMYLEstoneHealt...
(Date:11/23/2009)...A,Va.,Nov.23/PRNewswire/--JustintimefortheThanksgi...efswithtipsandrecipesforcookingupadeliciousmeal:de...andhealthinformation, turkeyfrying.net alsopro...aswellaspartyideasfortakingtheturkeybeyondThanksgi...lySouthernwayofdeep-fryingwith100%peanutoil. ,,...
Breaking Medicine News(10 mins):Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the glo...ounced that it will present key scientific data on...D) treatments lisdexamfetamine dimesylate (CII) an...CA. , , "Shire is committed to the advancement of...
... officials discuss strategy for a vaccine , ...ing sign that the swine flu outbreak has yet to ru...ew York City public schools were closed Thursday a...w York Mayor Michael Bloomberg said four students ...
... Boston Scientific Corporation (NYSE: BSX ) tod...and news announcements at the annual EuroPCR Scien...celona, Spain. , , "We are pleased to be announci...actical applications of the SYNTAX Score(TM)," sai...
... Quest Diagnostics Incorporated (NYSE: DGX ) an...ir physicians to share diagnostic laboratory test ...ection will enable physicians who use Quest Diagno...ant format into the patient,s protected account. P...
...5 Palatin Technologies, Inc. (NYSE Amex: PTN ) ...d March 31, 2009. Palatin reported net income of ..., for the quarter ended March 31, 2009, compared t...ere $5.2 million, compared to $0.7 million for the...
...as been known that aspirin is beneficial to patien... But which of the many different types of aspirin ...ers led by Dr. Sean Nordt from the University of C... chewed and swallowed, and chewable aspirin chewed...
Other Medicine News:Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 2Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 3Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 4Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 5Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 6Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 7Health News:Swine Flu Closes 3 Schools in NYC 2Health News:Swine Flu Closes 3 Schools in NYC 3Health News:Swine Flu Closes 3 Schools in NYC 4Health News:Swine Flu Closes 3 Schools in NYC 5Health News:Swine Flu Closes 3 Schools in NYC 6Health News:Swine Flu Closes 3 Schools in NYC 7Health News:Swine Flu Closes 3 Schools in NYC 8Health News:Swine Flu Closes 3 Schools in NYC 9Health News:Swine Flu Closes 3 Schools in NYC 10Health News:Boston Scientific Announces Schedule for EuroPCR 2009 2Health News:Boston Scientific Announces Schedule for EuroPCR 2009 3Health News:Boston Scientific Announces Schedule for EuroPCR 2009 4Health News:Boston Scientific Announces Schedule for EuroPCR 2009 5Health News:Boston Scientific Announces Schedule for EuroPCR 2009 6Health News:Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online 2Health News:Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 6
(Date:11/23/2009)...wswire-FirstCall/--Amgen(Nasdaq: AMGN )washonoredw...eandforBestNewDrugforNplate®(romiplostim),ata...neawardwaspresentedtoAmgenbyScripinrecognitionofth...y,spipeline,aswellasitsmixofcandidatesacrossdevelo...notableforitsfocusonunmetclinicalneed. ,, "Wear...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...agnosticImagingMarketto2015 ,, http://www.re...ic-Imaging-Market-to-2015.html#utm_source=prnewswi... ,, Description ,, TheFutureoftheDiagnos...lMarketsDirect,s"TheFutureoftheDiagnosticImagingMa...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...SandEMR ,, http://www.reportlinker.com/p0164...ewswire&utm_medium=pr&utm_campaign=prnewsw...most$1.3billion,representinganincreaseof6.7%over20...ediumhospitals(201-499beds),communityhospitals(200...
Breaking Medicine Technology:Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Kent State receives 242 7 million NSF training grant for environmental aquatic resource sensing 10643 1Kent State receives 242 7 million NSF training grant for environmental aquatic resource sensing 10643 2Doctors Point Out Gaps in U S Health Care 60776 1Doctors Point Out Gaps in U S Health Care 60776 2Practical Nursing Still a Growth Area in BC 60772 1Practical Nursing Still a Growth Area in BC 60772 2
...nced Cancer Patients, ROCKVILLE, Md., Dec. 4 Ent...rmaceutical company developing,therapeutics for th...oday,announced that it has commenced a multi-cente...th advanced pancreatic cancer. The primary objecti...or activity of,orally-administered MKC-1 in unrese...
...aluated Infrequent Dosing of Ustekinumab ...Pa. and BEERSE, Belgium, Dec. 4 Centocor, Inc.,an...hat regulatory,applications have been submitted re...n the United States and Europe for the treatment o...laque psoriasis. Centocor has,submitted a Biologic...
Other Medicine Technology:EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 2EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 3EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 4Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis 2Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis 3
Portex® Trach-Talk™ Blue Line® Tracheostomy Tubes
Portex Blue Line® Cuffed Fenestrated Tracheostomy Tubes
Portex Blue Line® Cuffed Tracheostomy Tubes
Bivona® TTS™ Tracheostomy Tubes
Medicine Products: